Providers, payers & startups are all looking for key pieces to solve the maternal care puzzle

America’s abysmal record on maternal care outcomes and equity has spurred the rise of startups as well as innovative strategies from providers and payers, each trying to solve a piece of the larger problem. But these entities will also need the help of policymakers to truly improve care in this arena.

Study: PE firms acquire hospitals with high operating margins, boosting them further

Hospitals acquired by PE firms tend to have higher operating margins than those that are not acquired — and that gap widens over time, a new study shows. But it is too early to say whether these glowing financial figures equate to better support for clinical care.

How do you get all the data quality benefits of eCOA in less time and at lower cost?

Upcoming oncology trial? Which oncology eCOA Package offers the best ability to capture reliable endpoint evidence to increase speed, reduce cost, and ensure consistency across sites and geographies in less time? Find out. Consider these data points: 334 studies 158,000+ patients 67 countries 44,000+ sites 116 languages 30+ indications 33% Faster Design with an Average …

How do you get all the data quality benefits of eCOA in less time and at lower cost? Read More »

Mercy, Anthem ink agreement to enhance care, drive down costs

The Missouri-based health system and payer have entered into a new cooperative care agreement that aims to reduce costs while improving both outcomes and patient experience. The agreement includes a closer alignment between clinical care and reimbursement as well as increased data flow between Mercy and Anthem.

DispatchHealth adds to evidence backing safety, efficacy of hospital-at-home programs

Amid the Covid-19 pandemic and a growing interest in at-home care, DispatchHealth has published new data showing that its hospital-at-home program did not result in unexpected deaths, serious adverse events or patients being subsequently admitted to a skilled nursing facility.